Loss of collagenase-2 confers increased skin tumor susceptibility to male mice

Nature Genetics

Volumn 35, Issue 3, 2003, Pages 252-257

  Balbín, Milagros ^a   Fueyo, Antonio ^b   Tester, Angus M ^c   Pendás, Alberto M ^a   Pitiot, Ana S ^a   Astudillo, Aurora ^d   Overall, Christopher M ^c   Shapiro, Steven D ^e   López Otín, Carlos ^a  

^a UNIVERSITY OF OVIEDO   (Spain)

^b DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; COLLAGENASE; GELATINASE A; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR; NEUTROPHIL COLLAGENASE; TAMOXIFEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BASEMENT MEMBRANE; CANCER SUSCEPTIBILITY; CELL PROTECTION; CONTROLLED STUDY; EMBRYO DEVELOPMENT; EXTRACELLULAR MATRIX; FEMALE; GENETIC MODEL; GENETIC SUSCEPTIBILITY; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; INFLAMMATORY CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEX DIFFERENCE; SKIN CARCINOGENESIS; SKIN TUMOR;

ANIMALS; BLOTTING, WESTERN; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; MALE; MATRIX METALLOPROTEINASE 8; MICE; MICE, KNOCKOUT; SEX FACTORS; SKIN NEOPLASMS;

ANIMALIA; UNIDENTIFIED AGENTS;

EID: 0242361314     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/ng1249     Document Type: Article

References (25)

1. Egeblad, M. & Werb, Z. New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2, 163-175 (2002).
2. Overall, C.M. & López-Otín, C. Strategies for MMP inhibition in cancer: innovations for the post-trial era. Nat. Rev. Cancer 2, 657-672 (2002).
3. Coussens, L.M., Fingleton, B. & Matrisian, L.M. Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 295, 2387-2392 (2002).
4. Moilanen, M., Pirila, E., Grenman, R., Sorsa, T. & Salo, T. Expression and regulation of collagenase-2 (MMP8) in head and neck squamous cell carcinomas. J. Pathol. 197, 72-81 (2002).
5. Brinckerhoff, C.E. & Matrisian, L.M. Matrix metalloproteinases: a tail of a frog that became a prince. Nat. Rev. Mol. Cell Biol. 3, 207-214 (2002).
6. Coussens, L.M. & Werb, Z. Inflammation and cancer. Nature 420, 860-867 (2002).
7. Devarajan, P., Mookhtiar, K., Van Wart, H. & Berliner, N. Structure and expression of the cDNA encoding human neutrophil collagenase. Blood 77, 2731-2738 (1991).
8. Balbin, M. et al. Collagenase 2 (MMP8) expression in murine tissue-remodeling processes: analysis of its potential role in postpartum involution of the uterus. J. Biol. Chem. 273, 23959-23968 (1998).
9. Herman, M.P. et al. Expression of neutrophil collagenase (matrix metalloproteinase-8) in human atheroma: a novel collagenolytic pathway suggested by transcriptional profiling. Circulation 104, 1899-1904 (2001).
10. Kiili, M. et al. Collagenase-2 (MMP8) and collagenase-3 (MMP-13) in adult periodontitis: molecular forms and levels in gingival crevicular fluid and immunolocalization in gingival tissue. J. Clin. Periodontol. 29, 224-232 (2002).
11. Pirila, E. et al. Gelatinase A (MMP-2), collagenase-2 (MMP8), and laminin-γ2-chain expression in murine inflammatory bowel disease (ulcerative colitis). Dig. Dis. Sci. 48, 93-98 (2003).
12. Quintanilla, M., Brown, K., Ramsden, M. & Balmain, A. Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis. Nature 322, 78-80 (1986).
13. Qin, Z., Kim, H.J., Hemme, J. & Blankenstein, T. Inhibition of methylcholanthrene-induced carcinogenesis by an interferon γ receptor-dependent foreign body reaction. J. Exp. Med. 195, 1479-1490 (2002).
14. Coussens, L.M., Shapiro, S.D., Soloway, P.D. & Werb, Z. Models for gain-of-function and loss-of-function of MMPs. Transgenic and gene targeted mice. Methods Mol. Biol. 151, 149-179 (2001).
15. Coussens, L.M., Tinkle, C.L., Hanahan, D. & Werb, Z. MMP9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 103, 481-490 (2000).
16. Knauper, V., López-Otín, C., Smith, B., Knight, G. & Murphy, G. Biochemical characterization of human collagenase-3. J. Biol. Chem. 271, 1544-1550 (1996).
17. Rovai, L.E., Herschman, H.R. & Smith, J.B. The murine neutrophil-chemoattractant chemokines LIX, KC, and MIP-2 have distinct induction kinetics, tissue distributions, and tissue-specific sensitivities to glucocorticoid regulation in endotoxemia. J. Leukoc. Biol. 64, 494-502 (1998).
18. Rossi, D. & Zlotnik, A. The biology of chemokines and their receptors. Annu. Rev. Immunol. 18, 217-242 (2000).
19. McQuibban, G.A. et al. Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3. Science 289, 1202-1206 (2000).
20. McQuibban, G.A. et al. Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1. J. Biol. Chem. 276, 43503-43508 (2001).
21. 2- and COOH-terminal truncations of murine granulocyte chemotactic protein-2 augment the in vitro and in vivo neutrophil chemotactic potency. J. Immunol. 163, 6155-6163 (1999).
22. 2-terminal heterogeneity. Eur. J. Biochem. 260, 421-429 (1999).
23. López-Otín, C. & Overall, C.M. Protease degradomics: a new challenge for proteomics. Nat. Rev. Mol. Cell Biol. 3, 509-519 (2002).
24. Puente, X.S., Sánchez, L.M., Overall, C.M., & López-Otín, C. Human and mouse proteases: a comparative genomic approach. Nat. Rev. Genet. 4, 544-558 (2003).
25. Ridger, V.C., Wagner, B.E., Wallace, W.A. & Hellewell P.G. Differential effects of CD18, CD29, and CD49 integrin subunit inhibition on neutrophil migration in pulmonary inflammation. J. Immunol. 166, 3484-3490 (2001).